Welcome!

News Feed Item

Product Clearance, Appointments, Upcoming Financial Results, and Clinical Study Results - Analyst Notes on Covidien, Medivation, United Therapeutics, Questcor and CareFusion

Editor Note: For more information about this release, please scroll to bottom.

NEW YORK, April 25, 2014 /PRNewswire/ --

Today, Analysts Review released its analysts' notes regarding Covidien plc (NYSE: COV), Medivation, Inc. (NASDAQ: MDVN), United Therapeutics Corporation (NASDAQ: UTHR), Questcor Pharmaceuticals, Inc. (NASDAQ: QCOR) and CareFusion Corporation (NYSE: CFN). Private wealth members receive these notes ahead of publication. To reserve complementary membership, limited openings are available at: http://www.analystsreview.com/1611-100free.

--
Covidien plc Analyst Notes
On April 14, 2014, Covidien plc (Covidien) announced the U.S. Food and Drug Administration (FDA) Clearance for the Kangaroo™ feeding tube with Integrated Real-time Imaging System (IRIS) Technology, the first-of-its-kind camera-equipped disposable feeding tube designed to enhance patient safety. The Company stated that the Covidien IRIS streams a real-time video back to the monitor, providing visual information that aids clinicians in identifying key areas of a patient's anatomy and also enables medical professionals in saving images from the live stream and making notes associated with the image. Jim Clemmer, President, Medical Supplies, Covidien, said, "Covidien is an industry leader in nutritional delivery and enteral feeding devices and products such as the Kangaroo feeding tube with IRIS technology are designed to help improve patient outcomes and set new expectations for medical device product safety and innovation around the world." The full analyst notes on Covidien are available to download free of charge at:

http://www.analystsreview.com/1611-COV-25Apr2014.pdf

--
Medivation, Inc. Analyst Notes
On April 17, 2014, Medivation, Inc. (Medivation) announced the appointment of Patrick Machado to the Company's Board of Directors, who recently retired as the Chief Financial and Business Officer. Commenting on the appointment, Kim D. Blickenstaff, Chairman, Medivation, said, "For the past nine years of having the honor of serving on the board of directors of Medivation, including seven as chairman, I've had the opportunity to observe the keen insight and vision that Pat Machado has brought to Medivation. I look forward to working with Pat in his new role, as he continues to help guide Medivation's efforts to develop novel therapies for serious diseases." The full analyst notes on Medivation are available to download free of charge at:

http://www.analystsreview.com/1611-MDVN-25Apr2014.pdf

--
United Therapeutics Corporation Analyst Notes
On April 22, 2014, United Therapeutics Corporation (United Therapeutics) announced that it will release its Q1 2014 financial results on April 29, 2014, before the market opens. The Company added that it will hold a half-hour teleconference on April 29, 2014, at 9:00 a.m. ET. United Therapeutics stated that the teleconference will be webcast and can be accessed via its website. The full analyst notes on United Therapeutics are available to download free of charge at:

http://www.analystsreview.com/1611-UTHR-25Apr2014.pdf

--
Questcor Pharmaceuticals, Inc. Analyst Notes
On April 21, 2014, Questcor Pharmaceuticals, Inc. (Questcor) announced results from an investigator-initiated clinical study that examined the dosing and effectiveness of H.P. Acthar® Gel in 20 patients with nephrotic syndrome due to idiopathic membranous nephropathy (iMN). According to the Company, the results demonstrated that Acthar Gel is proven to be a potentially useful therapy for inducing remission of proteinuria in patients suffering from nephrotic syndrome secondary to iMN. Questcor added that the study also showed that the clearance of anti-PLA2R antibodies, an immunological marker of iMN disease activity, preceded or paralleled improvements in proteinuria as a result of Acthar treatment in patients with detectable antibody levels. The Company further stated that Acthar Gel was well tolerated by patients during the course of the study, with the most common side effects being mood changes, weight gain, and transient insomnia. The full analyst notes on Questcor are available to download free of charge at:

http://www.analystsreview.com/1611-QCOR-25Apr2014.pdf

--
CareFusion Corporation Analyst Notes
On April 7, 2014, CareFusion Corporation (CareFusion) announced that it plans to release its Q3 FY 2014 financial results on May 5, 2014, after the close of trading on the New York Stock Exchange. The Company added that it will also host a conference call on the same day at 2:00 p.m. PDT (5:00 p.m. EDT). CareFusion stated that the call will be made accessible through the Investors Page of the Company website. The full analyst notes on CareFusion are available to download free of charge at:

http://www.analystsreview.com/1611-CFN-25Apr2014.pdf

--
About Analysts Review
We do things differently. Our goal is to provide the best content to our exclusive membership. We are constantly hiring researchers, writers, editors and analysts to add to our team and become better than yesterday. If being a part of a fast growing community with an edge in today's market sounds interesting to you, then sign-up today and experience the full benefits of membership.


===============
EDITOR'S NOTES:
===============

1. This is not company news. We are an independent source and our views do not reflect the companies mentioned.

2. Information in this release is fact checked and produced on a best efforts basis and reviewed by Nidhi Vatsal, a CFA charterholder. However, we are only human and are prone to make mistakes. If you notice any errors or omissions, please notify us below.

3. This information is submitted as a net-positive to companies mentioned, to increase awareness for mentioned companies to our subscriber base and the investing public.

4. If you wish to have your company covered in more detail by our team, or wish to learn more about our services, please contact us at pubco [at] http://www.analystsreview.com.

5. For any urgent concerns or inquiries, please contact us at compliance [at] http://www.analystsreview.com.

6. Are you a public company? Would you like to see similar coverage on your company? Send us a full investors' package to research [at] http://www.analystsreview.com for consideration.

COMPLIANCE PROCEDURE
Content is researched, written and reviewed on a best-effort basis. This document, article or report is prepared and authored by Analysts Review. An outsourced research services provider represented by Nidhi Vatsal, CFA, has only reviewed the information provided by Analysts Review in this article or report according to the procedures outlined by Analysts Review. Analysts Review is not entitled to veto or interfere in the application of such procedures by the outsourced provider to the articles, documents or reports, as the case may be.

NOT FINANCIAL ADVICE
Analysts Review makes no warranty, expressed or implied, as to the accuracy or completeness or fitness for a purpose (investment or otherwise), of the information provided in this document. This information is not to be construed as personal financial advice. Readers are encouraged to consult their personal financial advisor before making any decisions to buy, sell or hold any securities mentioned herein.

NO WARRANTY OR LIABILITY ASSUMED
Analysts Review is not responsible for any error which may be occasioned at the time of printing of this document or any error, mistake or shortcoming. No liability is accepted by Analysts Review whatsoever for any direct, indirect or consequential loss arising from the use of this document. Analysts Review expressly disclaims any fiduciary responsibility or liability for any consequences, financial or otherwise arising from any reliance placed on the information in this document. Analysts Review does not (1) guarantee the accuracy, timeliness, completeness or correct sequencing of the information, or (2) warrant any results from use of the information. The included information is subject to change without notice.

CFA® and Chartered Financial Analyst® are registered trademarks owned by CFA Institute.

AnalystsReview.com

SOURCE Analysts Review

More Stories By PR Newswire

Copyright © 2007 PR Newswire. All rights reserved. Republication or redistribution of PRNewswire content is expressly prohibited without the prior written consent of PRNewswire. PRNewswire shall not be liable for any errors or delays in the content, or for any actions taken in reliance thereon.

Latest Stories
20th Cloud Expo, taking place June 6-8, 2017, at the Javits Center in New York City, NY, will feature technical sessions from a rock star conference faculty and the leading industry players in the world. Cloud computing is now being embraced by a majority of enterprises of all sizes. Yesterday's debate about public vs. private has transformed into the reality of hybrid cloud: a recent survey shows that 74% of enterprises have a hybrid cloud strategy.
In the next five to ten years, millions, if not billions of things will become smarter. This smartness goes beyond connected things in our homes like the fridge, thermostat and fancy lighting, and into heavily regulated industries including aerospace, pharmaceutical/medical devices and energy. “Smartness” will embed itself within individual products that are part of our daily lives. We will engage with smart products - learning from them, informing them, and communicating with them. Smart produc...
Internet of @ThingsExpo, taking place June 6-8, 2017 at the Javits Center in New York City, New York, is co-located with the 20th International Cloud Expo and will feature technical sessions from a rock star conference faculty and the leading industry players in the world. @ThingsExpo New York Call for Papers is now open.
Providing the needed data for application development and testing is a huge headache for most organizations. The problems are often the same across companies - speed, quality, cost, and control. Provisioning data can take days or weeks, every time a refresh is required. Using dummy data leads to quality problems. Creating physical copies of large data sets and sending them to distributed teams of developers eats up expensive storage and bandwidth resources. And, all of these copies proliferating...
SYS-CON Events announced today that Catchpoint, a leading digital experience intelligence company, has been named “Silver Sponsor” of SYS-CON's 20th International Cloud Expo®, which will take place on June 6-8, 2017, at the Javits Center in New York City, NY. Catchpoint Systems is a leading Digital Performance Analytics company that provides unparalleled insight into your customer-critical services to help you consistently deliver an amazing customer experience. Designed for digital business, C...
“DevOps is really about the business. The business is under pressure today, competitively in the marketplace to respond to the expectations of the customer. The business is driving IT and the problem is that IT isn't responding fast enough," explained Mark Levy, Senior Product Marketing Manager at Serena Software, in this SYS-CON.tv interview at DevOps Summit, held Nov 4–6, 2014, at the Santa Clara Convention Center in Santa Clara, CA.
SYS-CON Events announced today that Catchpoint Systems, Inc., a provider of innovative web and infrastructure monitoring solutions, has been named “Silver Sponsor” of SYS-CON's DevOps Summit at 18th Cloud Expo New York, which will take place June 7-9, 2016, at the Javits Center in New York City, NY. Catchpoint is a leading Digital Performance Analytics company that provides unparalleled insight into customer-critical services to help consistently deliver an amazing customer experience. Designed ...
More and more brands have jumped on the IoT bandwagon. We have an excess of wearables – activity trackers, smartwatches, smart glasses and sneakers, and more that track seemingly endless datapoints. However, most consumers have no idea what “IoT” means. Creating more wearables that track data shouldn't be the aim of brands; delivering meaningful, tangible relevance to their users should be. We're in a period in which the IoT pendulum is still swinging. Initially, it swung toward "smart for smart...
WebRTC sits at the intersection between VoIP and the Web. As such, it poses some interesting challenges for those developing services on top of it, but also for those who need to test and monitor these services. In his session at WebRTC Summit, Tsahi Levent-Levi, co-founder of testRTC, reviewed the various challenges posed by WebRTC when it comes to testing and monitoring and on ways to overcome them.
The emerging Internet of Everything creates tremendous new opportunities for customer engagement and business model innovation. However, enterprises must overcome a number of critical challenges to bring these new solutions to market. In his session at @ThingsExpo, Michael Martin, CTO/CIO at nfrastructure, outlined these key challenges and recommended approaches for overcoming them to achieve speed and agility in the design, development and implementation of Internet of Everything solutions with...
In their general session at 16th Cloud Expo, Michael Piccininni, Global Account Manager - Cloud SP at EMC Corporation, and Mike Dietze, Regional Director at Windstream Hosted Solutions, reviewed next generation cloud services, including the Windstream-EMC Tier Storage solutions, and discussed how to increase efficiencies, improve service delivery and enhance corporate cloud solution development. Michael Piccininni is Global Account Manager – Cloud SP at EMC Corporation. He has been engaged in t...
Cloud Expo, Inc. has announced today that Andi Mann returns to 'DevOps at Cloud Expo 2017' as Conference Chair The @DevOpsSummit at Cloud Expo will take place on June 6-8, 2017, at the Javits Center in New York City, NY. "DevOps is set to be one of the most profound disruptions to hit IT in decades," said Andi Mann. "It is a natural extension of cloud computing, and I have seen both firsthand and in independent research the fantastic results DevOps delivers. So I am excited to help the great t...
Every successful software product evolves from an idea to an enterprise system. Notably, the same way is passed by the product owner's company. In his session at 20th Cloud Expo, Oleg Lola, CEO of MobiDev, will provide a generalized overview of the evolution of a software product, the product owner, the needs that arise at various stages of this process, and the value brought by a software development partner to the product owner as a response to these needs.
In 2014, Amazon announced a new form of compute called Lambda. We didn't know it at the time, but this represented a fundamental shift in what we expect from cloud computing. Now, all of the major cloud computing vendors want to take part in this disruptive technology. In his session at 20th Cloud Expo, John Jelinek IV, a web developer at Linux Academy, will discuss why major players like AWS, Microsoft Azure, IBM Bluemix, and Google Cloud Platform are all trying to sidestep VMs and containers...
SYS-CON Events announced today that MobiDev, a client-oriented software development company, will exhibit at SYS-CON's 20th International Cloud Expo®, which will take place June 6-8, 2017, at the Javits Center in New York City, NY, and the 21st International Cloud Expo®, which will take place October 31-November 2, 2017, at the Santa Clara Convention Center in Santa Clara, CA. MobiDev is a software company that develops and delivers turn-key mobile apps, websites, web services, and complex softw...